Ketamine Therapy for Depression in India: An Honest Guide

Ketamine-based treatment for depression is considered in specialist medical care, mainly for treatment-resistant depression under direct psychiatric supervision. Evidence and regulatory conditions differ between intravenous ketamine and the nasal-spray medicine esketamine. In India, ask a psychiatrist about local eligibility, regulation, and licensed medical settings; never try to arrange or use ketamine yourself.

This guide explains how it works, who it is actually for, what the evidence and the risks look like, and how to evaluate an Indian clinic honestly. Boli's role here is the usual one: emotional support around a medical journey that belongs entirely to qualified doctors.

What ketamine treatment actually is

Ketamine is an established anaesthetic that has also been studied at different doses for rapid antidepressant effects. Intravenous ketamine for depression and esketamine nasal spray are not interchangeable products. The US FDA has approved esketamine for specific depression indications with monitoring and restricted-distribution requirements; those US conditions should not be presented as Indian approval.

Any ketamine-based depression treatment should involve psychiatric assessment, a licensed medical setting, monitoring, and a plan for what happens after the initial sessions. An offer that skips medical supervision is a safety red flag, not a convenience.

Who it is for — and who it is not for

The evidence base centres on treatment-resistant depression: adults whose depression has not responded adequately to standard antidepressant trials, as assessed by a psychiatrist. Research bodies including the US National Institute of Mental Health describe rapid-acting antidepressant effects in this group, with ongoing study of how long benefits last and how best to maintain them.

It is not a first-line treatment for a first depressive episode, not a wellness booster, and not suitable for everyone—history of psychosis, certain heart conditions, pregnancy, and substance-use history all change the calculus. The screening assessment exists to catch exactly these factors, which is why a legitimate provider always starts with one.

What a treatment course looks like

Sessions involve dissociative effects—feeling detached or dream-like for a period—which settle under observation. Blood pressure is monitored. The treating team explains side effects and aftercare; if a provider cannot describe these plainly, that tells you what you need to know about the provider.

Availability and cost in India

Availability and regulatory status can differ by product, indication, and institution in India. The practical route is a conversation with a treating psychiatrist, followed by verification of the facility and medicine—not a cold search for a “ketamine clinic.” CDSCO materials document ketamine as a controlled prescription medicine because of its medical use and misuse potential.

If a licensed service is clinically appropriate and locally available, ask for the complete treatment estimate, monitoring plan, and current insurance position in writing. Do not infer Indian approval or insurance coverage from US esketamine information.

Questions that separate real clinics from hype

Ask: Is a psychiatrist assessing me and supervising every session? Which form is used—IV ketamine or esketamine—and why that choice for me? What monitoring happens during and after sessions? What is the plan if I do not respond, and what does maintenance look like if I do? What is the total course cost?

Walk away from any provider promising guaranteed results, marketing to people without treatment-resistant histories, minimising side effects, or offering unsupervised or at-home use. The treatment is legitimate medicine in the right hands and genuinely risky outside them.

Where Boli fits around ketamine treatment

Considering an intensive treatment stirs up feelings that deserve words: hope you are afraid to trust, family members with opinions, the weariness of the treatment road so far. Boli's Maya, Priya, and Neha are Hinglish AI companions for exactly those conversations—rehearsing what to ask the psychiatrist, unloading the night before screening, processing a session day.

An AI companion has no role in the medical side: no advice on eligibility, dosing, or clinics. Emotional support around the journey; doctors for the journey itself.

When to seek help immediately

Interest in rapid-acting treatment sometimes comes from a dangerous place. If you are having thoughts of self-harm or suicide tonight, the answer is immediate human help, not a clinic waitlist: Tele-MANAS 14416 or 112 in an emergency. Rapid help exists tonight; rapid treatment can be discussed after.

Frequently Asked Questions

Is ketamine treatment for depression legal in India?

Ketamine is a controlled prescription anaesthetic in India. Whether a specific ketamine or esketamine product and depression indication is authorised or offered locally is a question for a psychiatrist, the treating institution, and current CDSCO information. Do not buy or use ketamine outside licensed medical care.

How fast does ketamine work for depression?

Research shows antidepressant effects can appear within hours to days of a session—much faster than oral antidepressants. Effects of a single session fade, which is why treatment runs as a supervised series with a maintenance plan rather than a one-time fix.

Is ketamine treatment addictive?

Ketamine has known misuse potential, which is one reason clinical use is tightly supervised, doses are controlled, and take-home use is not part of legitimate depression treatment. Screening covers substance-use history, and monitoring continues through the course.

Can Boli tell me whether I should try ketamine therapy?

No. That is a medical eligibility decision for a psychiatrist who knows your history. Boli's AI companions can help you sort out your feelings and questions before that appointment—which is a genuinely useful, and honestly limited, role.

Ketamine therapy is real medicine for a specific situation: treatment-resistant depression, under psychiatric supervision, in a monitored clinical setting. If that describes your situation, route the question through your treating psychiatrist, interrogate any clinic with the questions above, and keep both the hope and the caution—the evidence supports carrying both.